The association between coronary graft patency and clinical status in patients with coronary artery disease

Mario Gaudino1, Antonino Di Franco1, Deepak L Bhatt2

  • 1Department of Cardiothoracic Surgery, Weill Cornell Medicine, 525 E 68th St, New York, NY 10065, USA.

European Heart Journal
|March 12, 2021
PubMed

Insights

Coronary graft patency impacts clinical status, but this link is complex. Graft occlusion often leads to non-fatal events, with severity depending on graft type and patient factors.

Area of Science:

  • Cardiology
  • Vascular Surgery
  • Medical Imaging

Background:

  • The link between coronary graft patency and patient clinical status is widely accepted but often oversimplified.
  • Variability in defining graft occlusion and standardizing imaging protocols complicates assessment after coronary bypass surgery.

Purpose of the Study:

  • To systematically review and synthesize evidence on the association between coronary graft status (patency and occlusion) and clinical outcomes.
  • To explore the complexities and modulating factors influencing the relationship between graft patency and clinical status.

Main Methods:

  • Systematic review of existing literature.
  • Analysis of factors influencing graft patency-clinical status association, including graft type, occlusion timing, myocardial territory, and patient baseline characteristics.

Main Results:

  • Graft occlusion is more frequently linked to non-fatal clinical events than to mortality.
  • Graft failure due to competitive flow generally presents as a benign event.
  • Graft occlusion in a graft-dependent circulation is significantly associated with the occurrence of clinical symptoms.

Conclusions:

  • The relationship between coronary graft patency and clinical outcomes is intricate and influenced by multiple factors.
  • Understanding these nuances is crucial for accurate patient assessment and management following coronary bypass surgery.

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
115
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
79
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
138
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
167
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
639
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
120